» Articles » PMID: 19203586

PH Domain-only Protein PHLDA3 is a P53-regulated Repressor of Akt

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2009 Feb 11
PMID 19203586
Citations 136
Authors
Affiliations
Soon will be listed here.
Abstract

p53 And Akt are critical players regulating tumorigenesis with opposite effects: whereas p53 transactivates target genes to exert its function as a tumor suppressor, Akt phosphorylates its substrates and transduces downstream survival signals. In addition, p53 and Akt negatively regulate each other to balance survival and death signals within a cell. We now identify PHLDA3 as a p53 target gene that encodes a PH domain-only protein. We find that PHLDA3 competes with the PH domain of Akt for binding of membrane lipids, thereby inhibiting Akt translocation to the cellular membrane and activation. Ablation of endogenous PHLDA3 results in enhanced Akt activity and decrease of p53-dependent apoptosis. We also demonstrate the suppression of anchorage-independent cell growth by PHLDA3. Loss of the PHLDA3 genomic locus was frequently observed in primary lung cancers, suggesting a role of PHLDA3 in tumor suppression. Our results reveal a new mode of coordination between the p53 and Akt pathways.

Citing Articles

Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells.

Miciak J, Petrova L, Sajwan R, Pandya A, Deckard M, Munoz A Oncotarget. 2025; 16:79-100.

PMID: 39969205 PMC: 11837864. DOI: 10.18632/oncotarget.28690.


Extrinsic induction of apoptosis and tumor suppression via the p53-Reprimo-Hippo-YAP/TAZ-p73 pathway.

Takikawa M, Nakano A, Krishnaraj J, Tabata Y, Watanabe Y, Okabe A Proc Natl Acad Sci U S A. 2025; 122(6):e2413126122.

PMID: 39913207 PMC: 11831151. DOI: 10.1073/pnas.2413126122.


Enhancer regulatory networks globally connect non-coding breast cancer loci to cancer genes.

Wang Y, Armendariz D, Wang L, Zhao H, Xie S, Hon G Genome Biol. 2025; 26(1):10.

PMID: 39825430 PMC: 11740497. DOI: 10.1186/s13059-025-03474-0.


CYFIP2: potential pancreatic cancer biomarker and immunotherapeutic target.

Xiao C, Zhang X, Hou B, Wan P, Cao Z, Rao X Discov Oncol. 2024; 15(1):847.

PMID: 39739214 PMC: 11685368. DOI: 10.1007/s12672-024-01650-5.


Inhibition of expression in human superoxide dismutase 1-mutant amyotrophic lateral sclerosis astrocytes protects against neurotoxicity.

Szebenyi K, Vargova I, Petrova V, Tureckova J, Gibbons G, rehorova M Brain Commun. 2024; 6(4):fcae244.

PMID: 39144751 PMC: 11323778. DOI: 10.1093/braincomms/fcae244.